Lexeo Therapeutics, Inc. (LXEO) (CIK 0001907108) CORRESP
A CORRESP letter is the company's written reply to the SEC during a filing review. Responses include accounting position arguments, restatement assessments, and clarifying disclosures. Released to EDGAR alongside the SEC's UPLOAD letters.
Key facts
- Accession number
- 0001193125-25-297231
- Form
- CORRESP
- Filer
- Lexeo Therapeutics, Inc. (LXEO) (CIK 0001907108)
- CIK
- 0001907108
- Ticker
- LXEO
- Filed
- 2025-11-25
- SIC industry
- 2836
- HQ
- New York, NY
Primary source
PDF letter: https://www.sec.gov/Archives/edgar/data/1907108/000119312525297231/filename1.htm
EDGAR review index: browse all UPLOAD/CORRESP for this filer ↗